Island Pharmaceuticals Ltd
ASX:ILA
Cash Flow Statement
Cash Flow Statement
Island Pharmaceuticals Ltd
| Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||
| Stock-Based Compensation |
0
|
1
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
|
| Cash from Operating Activities |
(2)
N/A
|
(2)
-32%
|
(3)
-9%
|
(3)
-1%
|
(3)
-16%
|
(3)
+9%
|
|
| Investing Cash Flow | |||||||
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | |||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
3
|
7
|
|
| Net Issuance of Debt |
0
|
(0)
|
0
|
0
|
0
|
(0)
|
|
| Other |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
0
N/A
|
(0)
N/A
|
(0)
-137%
|
0
N/A
|
3
+1 298%
|
6
+111%
|
|
| Change in Cash | |||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
(2)
N/A
|
(2)
-43%
|
(3)
-16%
|
(2)
+12%
|
(0)
+86%
|
3
N/A
|
|
| Free Cash Flow | |||||||
| Free Cash Flow |
(2)
N/A
|
(2)
-32%
|
(3)
-9%
|
(3)
-1%
|
(3)
-16%
|
(3)
+9%
|
|